Skip to content

Clinical trials

Completed Cardiomyopathy, Hypertrophic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Status: Completed Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20153
20183
20192
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Bordeaux3
Cytokinetics2
French Cardiology Society2
University Hospital, Montpellier2
Bristol-Myers Squibb1
Centre Hospitalier Universitaire, Amiens1
Hospices Civils de Lyon1
MyoKardia, Inc.1
Pfizer1
Thibaud Damy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic15
Cardiomyopathy, Dilated3
Brugada Syndrome2
Long QT Syndrome2
Polymorphic Catecholaminergic Ventricular Tachycardia2
Amyloid Neuropathies, Familial1
Arrhythmogenic Right Ventricular Dysplasia1
Bites and Stings1
Cardiomyopathy, Restrictive1
Death, Sudden1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.